Judge Michael Kaplan ruled that Rite Aid is not liable for over $200m in Elixir acquisition costs, making MedImpact responsible.
Judge Michael Kaplan ruled that Rite Aid is not responsible for over $200m in extra costs tied to the acquisition of Elixir by MedImpact. The ruling states that the underlying Elixir sale agreement makes MedImpact responsible for the disputed liabilities, which include unpaid reimbursements owed to CVS, Walgreens, and Walmart. The decision supports Rite Aid as it works to exit bankruptcy, saving it from additional expenses.
June 24, 2024
5 Articles